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a b s t r a c t
The Hippo signaling pathway is involved in regulating tissue size by inhibiting cell proliferation and
promoting apoptosis. Aberrant Hippo pathway function is often detected in human cancers and
correlates with poor prognosis. The Drosophila C-terminal Src kinase (d-Csk) is a genetic modiﬁer of
warts (wts), a tumor-suppressor gene in the Hippo pathway, and interacts with the Src oncogene.
Reduction in d-Csk expression and the consequent activation of Src are frequently seen in several cancers
including hepatocellular and colorectal tumors. Previous studies show that d-Csk regulates cell
proliferation and tissue size during development. Given the similarity in the loss-of-function phenotypes
of d-Csk and wts, we have investigated the interactions of d-Csk with the Hippo pathway. Here we
present multiple lines of evidence suggesting that d-Csk regulates growth via the Hippo signaling
pathway. We show that loss of dCsk caused increased Yki activity, and our genetic epistasis places dCsk
downstream of Dachs. Furthermore, dCsk requires Yki for its growth regulatory functions, suggesting
that dCsk is another upstream member of the network of genes that interact to regulate Wts and its
effector Yki in the Hippo signaling pathway.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Growth regulation requires a balance between cell proliferation
and cell death (Raff, 1996; Stanger, 2008). Amongst these pathways
the Hippo pathway regulates organ size by inhibiting cell prolifera-
tion and promoting apoptosis in all metazoan animals from
Drosophila to mammals (Schroeder and Halder, 2012; Staley and
Irvine, 2012; Tumaneng et al., 2012; Yu and Guan, 2013). The Hippo
pathway is a network of tumor suppressor genes and oncogenes,
and mutations in Hippo pathway lead to overgrowth of the
imaginal discs and adult organs (Kango-Singh and Singh, 2009).
Aberrant Hippo pathway function in humans (due to ampliﬁcation
of genes, epigenetic silencing and oncogenic transformation) is
often detected in human cancers and correlates with poor prognosis
(Halder and Camargo, 2013; Harvey et al., 2013; Johnson and
Halder, 2014; Pan, 2010; Zeng and Hong, 2008).
The Hippo pathway comprises of a core kinase cascade involving
the Ste-20 family kinase Hippo (Hpo) (Harvey et al., 2003; Jia et al.,
2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) and
the DMPK family kinase Warts (Wts) (Justice et al., 1995; Xu et al.,
1995), which acts upon the transcriptional co-activator Yorkie (Yki)
(Huang et al., 2005). Nuclear availability of Yki is regulated by
phosphorylation-dependent and -independent mechanisms (Badouel
et al., 2009; Oh and Irvine, 2008, 2010; Oh et al., 2009). Wts-mediated
phosphorylation of Yki causes its cytoplasmic localization and degra-
dation. When Hippo signaling is down-regulated, active Yki translo-
cates to the nucleus where it forms a complex with the transcription
factor Scalloped (Sd) [or Mothers against Dpp (MAD), Teashirt (Tsh)
or Homothorax (Hth)] to induce the expression of target genes
that promote (a) cell proliferation and cell survival like the bantam
miRNA, myc, (b) cell cycle progression e.g., E2F1, cyclins A, B, E, and
(c) inhibitors of apoptosis like drosophila inhibitor of apoptosis (diap1)
(Edgar, 2006; Enderle and McNeill, 2013; Halder and Camargo, 2013;
Halder and Johnson, 2011; Kango-Singh and Singh, 2009; Saucedo and
Edgar, 2007). Hippo signaling also regulates the expression of several
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genes within its pathway via a negative feedback loop (Edgar, 2006;
Kango-Singh and Singh, 2009; Saucedo and Edgar, 2007). Thus, there
are several upstream regulators of Yki in the Hippo pathway, and the
Hippo pathway activity shows context-dependent response to these
upstream inputs (Grusche et al., 2010; Halder and Johnson, 2011).
Recent studies have revealed that the Hippo pathway cross-talks with
other signaling pathways (e.g., TGFb/Dpp, Wnt/Wg, EGFR/MAPK, G-
Protein Coupled Receptors[GPCRs]) in several contexts(Boggiano and
Fehon, 2012; Mauviel et al., 2012; Schroeder and Halder, 2012; Staley
and Irvine, 2012). We tested the interaction of C-terminal Src kinase
(Csk), a Src-family protein tyrosine kinase (SFK) (Okada, 2012; Read
et al., 2004; Stewart et al., 2003) with the Hippo pathway, to
investigate the mechanism of growth regulation by SFKs—an area that
remains poorly understood.
Analogous to the role of the Hippo pathway, the SFKs are involved
in the regulation of normal development, and their misregulation is
implicated in several types of cancers (Ingley, 2008; Okada, 2012).
This family of proteins is regulated by signaling pathways (e.g., GPCRs)
that are involved in the regulation of cell cycle entry, cyto-skeletal
rearrangement and cell-adhesion. Src proteins are maintained in
inactive state by C-terminal Src kinase (Csk), a conserved Src family
kinase (SFK) (Imamoto and Soriano, 1993; Okada, 2012). C-terminal
Src kinase (Csk) maintains SFKs in an inactive state by an inhibitory
phosphorylation (e.g., Tyr527 in avian c-Src) (Cole et al., 2003). Csk
acts as a tumor-suppressor gene by interacting with several signaling
proteins via phosphorylation-mediated interactions (e.g., Paxillin,
c-Jun, Lats) (reviewed by Okada (2012)). Mammalian Src is well
known for mitogenic signaling, and can act as a proapoptotic or anti-
apoptotic signal by its context-dependent interactions with the Ras-
MAPK, PI3 Kinase/Akt, and Stat3 signaling pathways (Alexander et al.,
2004; Martin, 2006; Thomas and Brugge, 1997). Thus, tissue context
decides the outcome of Src activation.
The Drosophila Csk homolog, dCsk, acts as a tumor suppressor
gene because loss of dCsk in homozygous mutant animals results
in hyperplasia of imaginal discs (Read et al., 2004; Stewart et al.,
2003), whereas loss of dCsk in somatic clones results in poor
growth of the mutant cells (Read et al., 2004; Vidal et al., 2006).
Loss of dCsk using a RNAi approach (UASdCsk-IR) showed that large
patches of dCsk mutant cells lead to increased proliferation and
decreased apoptosis (Vidal et al., 2006), and effects of loss of dCsk
are mediated through Src activation(Read et al., 2004). Although
Src expression is elevated in several tumors (Yeatman, 2004), Src
overexpression in epithelial cells in ﬂies is known to cause both
proliferation and apoptosis (Vidal et al., 2007). Recently, activation
of Src oncoprotein was shown to activate Yki in a JNK-dependent
manner (Enomoto and Igaki, 2013). Over-expression of Src caused
Rac-Diaphanous and Ras-MAPK activation (Enomoto and Igaki,
2013), which cooperatively activate F-actin a Hippo pathway target
gene (Fernandez et al., 2011; Richardson, 2011; Sansores-Garcia et
al., 2011). These studies revealed that both the cell autonomous
and the non-cell autonomous effects of Src activation depend on
JNK mediated Yki regulation (Enomoto and Igaki, 2013). Further-
more, dCsk is known as a genetic modiﬁer of Wts, and is known to
phosphorylate Wts (Pedraza et al., 2004; Stewart et al., 2003).
Given that the growth regulatory functions of Wts occur
through its interactions with Yki and the Hippo signaling pathway,
we proposed that dCsk regulates growth via the Hippo signaling
pathway. We tested if loss of dCsk resulted in changes in Yki
activity levels, and if dCsk and Hippo pathway genes genetically
interact. We present multiple lines of evidences suggesting that
loss of dCsk using RNAi mediated elimination of dCsk in large
patches of cells causes overgrowth due to increased proliferation –
due to increased Yki activity. The effects of loss of dCsk are cell
autonomous, and genetic interactions between dCsk and Hippo
pathway components place dCsk between Dachs and Zyx that
function downstream of Fat in the Hippo network.
Material and methods
Fly stocks
The following strains were obtained from the Bloomington Stock
Center unless otherwise speciﬁed: UASdCsk-IR; þ; TM3Sb/SM6a-
TM6B, Tb (from R. Cagan), y w; FRT82B dCskQ156Stop (from R. Cagan),
yw; UASRasV12; FRT82B dCskQ156stop (from R. Cagan), yw hsFlp; nub-
Gal4 UASHpoRNAi/CyO-GFP (from G. Halder), yw; nub-Gal4 UASH-
poΔINH/CyORoi (from G. Halder), Ubx-Flp; FRT42D ykiB5/CyO (from D.J.
Pan), UASWts13F (from G. Halder), UASFtRNAi (VDRC # V9396),
UASScribRNAi, UASDV5, UASZyxRNAi, UASYkiV5, en-GAL4 UASGFP, ex697
en-GAL4 (from G.Halder), and nub-Gal4. To test the loss-of-function
phenotype of dCsk, we generated the line UASdCsk-IR; nub-Gal4/CyO
by using appropriate genetic crosses. This line was outcrossed to
other UAS-bearing transgenes to study genetic interactions between
dCsk and Hippo pathway genes. Other crosses were performed to
create the following lines: (1) UASdCsk-IR; nub-Gal4 UASDV5/CyO, (2)
UASdCsk-IR; ex697-lacZ/CyO, (3) UASdCsk-IR; fj-lacZ/CyO, (4) UASdCsk-
IR; Diap1-4.3 GFP/TM6B, Tb, (5) MS-1096; ex-lacZ/CyO, (6) MS-1096;
fj-lacZ/CyO, and (7)MS-1096; Diap1-4.3 GFP/TM6B. Flies were grown
at 25 1C unless noted otherwise.
Immunohistochemistry
Immunohistochemistry was done following the previously
published protocol (Kango-Singh et al., 2002). Brieﬂy, wing imagi-
nal discs from third-instar larvae were dissected in phosphate
buffered saline (PBS), ﬁxed for 20 min in 4% paraformaldehyde,
and washed twice for 10 min each in PBST (PBSþ0.2% TritonX-
100) at room temperature. Tissues were then blocked with 2%
normal donkey serum for 2 h and stained with primary antibody
at 4 1C overnight. Next, tissues were washed twice and incubated
in secondary antibody for 2 h at room temperature in foil-wrapped
eppendorf tubes. Finally, tissues were mounted in Vectashield
after three rounds of washing. Images were taken using confocal
microscopy. The following primary antibodies were used: mouse-
anti DIAP1 (1:250); mouse-anti βgal (1:100), mouse-anti Wingless
(1:100), and rabbit-anti Caspase (1:250). Secondary antibodies
(Jackson Immunoresearch) used were anti-mouse Cy3 (1:1000)
and anti-rabbit Cy3 (1:1000). The samples were imaged using an
Olympus Fluoview 1000 Laser Scanning confocal microscope, and
the images were processed using Adobe Photoshop CS6.
Quantiﬁcation of disc size
The size of the wing pouch was measured using the expression
of Wg as a guide for the extent of the nub-GAL4 domain (Fig. S1,
Fig. 4). The size of the wing pouch was measured by marking the
edges Wg expression in the wing disc corresponding to region of
the wing margin. The area of the wing pouch was measured (in
pixels) using the histogram function in Adobe Photoshop CS6.0 for
each genotype (n¼5). A two-tailed T-test was performed using
Excel 2013 to quantify if the observed differences between pouch
sizes were signiﬁcant (po0.05).
Adult ﬂy wing mounting and imaging
Adult ﬂies were collected in 70% ethanol and dehydrated in an
ascending alcohol series. The wings of completely dehydrated ﬂies
were clipped in 100% ethanol and mounted in Canada Balsam (3
Canada Balsam: 1 Methyl Salicylate). Wings were photographed
using an Olympus BX51 Microscope mounted with an Olympus
XM10 camera and images acquired using the CellSens Dimensions
Software. Adult ﬂies showing no-wing phenotype were maintained
at 4 1C overnight before they were mounted. Adult ﬂy images were
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taken with the Zeiss Apotome microscope, and Z-stack projections
were generated using Axiovision software.
Results
Loss of dCsk in large patches results in overgrowth
To study the effects of loss of dCsk, we overexpressed UASdCsk-IR
(Vidal et al., 2006) in the wing pouch using the nubbin-GAL4 (nub-
GAL4) driver (Fig. 1a). The UASdCsk-IR is an inverted repeat (IR)
containing transgene that targets the dCsk transcript (Vidal et al.,
2006). The nub-GAL4 driver is expressed in the wing pouch
(Neumann and Cohen, 1998). We used the expression of Wingless
(Wg) to mark the boundary of the wing pouch, as the edge of nub
expression overlaps with the outer wing hinge-speciﬁc expression
of Wg (Neumann and Cohen, 1998). Compared to wild-type (a–d),
loss of function of dCsk resulted in large overgrowths in the wing
pouch in imaginal discs (Fig. 1g–i) and in adult wings (Fig. 1
compare e to f). Earlier studies have also shown that loss of dCsk
in homozygous discs induces apoptosis (Langton et al., 2007);
therefore, we tested the effects of loss of dCsk (UASdCsk-IR; nub-
GAL4/þ) on cell death using antibodies against activated Caspase 3
(Casp3n) and the Drosophila Inhibitor of Apoptosis Protein 1
(DIAP1). Compared to wing imaginal discs that show wild-type
expression of Wg (Fig. 1b), activated Caspase 3 (Fig. 1c) and DIAP1
(Fig. 1d), loss of dCsk (UASdCsk-IR; nub-GAL4/þ) caused overgrowth
of the wing pouch accompanied by mild induction of activated
Caspase 3 (Casp3n) (Fig. 1h), and a remarkable downregulation of
DIAP1 (Fig. 1i) expression.
On the other hand, compared to wild-type clones (Fig. 2a–c),
small patches of dCsk mutant cells generated using an MARCM
approach (Lee and Luo, 1999), resulted in small clones that did not
overgrow (Fig. 2d green, gray in e). dCsk mutant clones resulted in
strong upregulation of Casp 3n in the eye (Fig. 2c) and wing discs
(data not shown). This phenotype of loss of dCsk in somatic clones
differs from the effects of loss of dCsk in larger regions of the discs
where dCsk mutant cells can overcome apoptosis and cause over-
growth (compare Fig. 2d to Fig. 1g). Earlier studies have shown
that loss of dCsk causes microenvironment speciﬁc phenotypes,
e.g., loss of dCsk over larger areas of the wing discs using 769-GAL4
or omb-GAL4 results in enlarged wings, whereas somatic clones of
dCsk fail to survive (Vidal et al., 2006). Consistent with these
reports, further analysis of the dCskmutant clones (Fig. 2) revealed
that the mutant cells were competed out by the surrounding wild-
type cells, and resulted in no developmental defects in the adult
ﬂy. Taken together, loss of dCsk results in context dependent
effects on growth, together with mild effects on apoptosis despite
downregulation of DIAP1.
Loss of dCsk affects Yki activity
The overgrowth phenotypes resulting from loss of dCsk are similar
to the effects of loss of function of Hippo pathway genes like expanded
(ex), merlin (mer) and fat (ft), that induce excess cell proliferation and
mild effects on apoptosis in mutant cells resulting in formation of
larger structures(Bennett and Harvey, 2006; Pellock et al., 2007; Silva
et al., 2006; Willecke et al., 2006). Therefore, we tested the effect of
loss of dCsk on transcriptional targets of Hippo signaling (ex-lacZ, fj-
lacZ, and diap4.3GFP) (Fig. 3, Fig. S1). Compared to the wild-type
expression of ex-lacZ (Fig. 3a–c), and fj-lacZ (Fig. 3g–i), downregulation
of dCsk using en-GAL4 in the posterior compartment of the wing disc
results in upregulation of ex-lacZ (Fig. 3d–f) and fj-lacZ (Fig. 3j–l)
suggesting that loss of dCsk leads to Yki activation. We conﬁrmed this
observation as dCsk downregulation in the wing pouch under nub-
GAL4 (UASdCsk-IR; nub-GAL4/þ) upregulates the levels of expression
of ex-lacZ (Fig. S1a andb) and fj-lacZ (Fig. S1c and d). We also tested the
expression of diap1-4.3GFP, the reporter transgene that contains the
Hippo response element in diap1 (Wu et al., 2008; Zhang et al., 2008),
to check if loss of dCsk affects diap1 expression via the Hippo pathway.
Compared to the expression of the diap1-4.3GFP in wild type wing
discs (Fig. S1e), we observed a downregulation of diap14.3-GFP
Fig. 1. Loss of function phenotypes of dCsk. Panels show comparison of wing imaginal discs from third instar larvae of wild-type (a–d) and UASdCsk-IR; nub-GAL4/þ (g–i) and
corresponding adult wing phenotypes (e and f). The nub-Gal domain is shown using GFP expression (a), and wild-type expression of Wg (b), activated Caspase 3 (Casp3*) (c),
and DIAP1 (d) is shown. Loss of dCsk in the nub-Gal4 expression domain causes overgrowth of the wing pouch (f). Regulation of Wingless expression during dCsk loss-of-
function reveals over-proliferation of cells in the wing pouch (g). The overgrowth of dCsk mutant cells occurs despite induction of Casp3* (h) and down-regulation of DIAP1
(i). The resulting adult wing phenotype is shown in panels e and f.
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expression in wing discs from UASdCsk-IR; nub-GAL4/þ larvae (Fig.
S1f). This effect is similar to downregulation of DIAP1 protein in dCsk
mutant cells. Taken together, this data suggests that loss of dCsk results
in increased Yki activity leading to upregulation of ex and fj transcrip-
tion, but not diap1 transcription. This increased Yki activity may in part
explain the overgrowth phenotype of the UASdCsk-IR; nub-GAL4/þ
wing discs.
dCsk genetically interacts with the Hippo pathway
Since the phenotypes of dCsk suggested that dCsk caused increased
Yki activity, we tested if dCsk genetically interacted with Hippo
pathway genes using genetic epistasis approaches (Figs. 4, 5, S2).
For all epistasis experiments, we used two criteria to analyze the
interaction. First, we tested for the effects of epistatic interactions on
DIAP1 expression, and second, we compared the size of the wing
pouch. Previous studies identiﬁed dCsk as a genetic modiﬁer of loss-
or gain-of-function phenotypes of Wts (Stewart et al., 2003). Wts acts
downstream of dCsk to mediate its growth regulatory functions
in vivo, and dCsk phosphorylates Wts in-vitro (Pedraza et al., 2004;
Stewart et al., 2003). We conﬁrmed this epistatic interaction between
dCsk and Wts using our experimental system in the wing pouch
(Fig. 4a–d). Over-expression of UASWts results in hyperactivation of
the Hippo pathway and results in smaller organs due to increased
apoptosis (Tapon et al., 2002; Verghese et al., 2012b). Over-expression
of UASWts under nub-GAL4 results in reduction of wing pouch size
(Fig. 4a and b). Co-expression of UASWts with UASdCsk-IR (Fig. 4c and
d) resulted in a complete suppression of dCsk phenotype of over-
growth (Fig. 1g–i), suggesting that dCsk acts upstream of Wts.
Next, we tested the genetic interaction between Hpo and dCsk.
Overexpression of UASHpo results in induction of apoptosis and
reduction in organ size (Udan et al., 2003; Verghese et al., 2012a;
Wu et al., 2003). Over-expression of UASHpo under nub-GAL4 results
in smaller wing pouch (Fig. 4e and f), and co-expression of UASdCsk-
IR and UASHpo resulted in generation of small wings (Fig. 4g and h)
akin to the phenotype of Hpo overexpression suggesting that dCsk
acts upstream of Hpo. Taken together, these data suggests that dCsk
interacts with the core components of the Hippo pathway to regulate
cell proliferation, and tissue sizes.
Next, we extended our investigation of genetic interactions bet-
ween dCsk with two other upstream components of the Hippo
pathway—Zyxin (Zyx) (Rauskolb et al., 2011), and Dachs (D) (Mao
et al., 2006). Zyx and D act downstream of the atypical cadherin Fat
and are known to negatively regulate levels of Wts protein (Mao
et al., 2006; Matakatsu and Blair, 2008; Rauskolb et al., 2011).
Downregulation of Zyx (using UASZyxRNAi) results in an overall
reduction in the wing pouch (Fig. 4i and j). Co-expression of
UASdCsk-IR with UASZyxRNAi phenocopies the UASZyxRNAi phenotype
of reduction in wing pouch (Fig.4k and l), suggesting that dCsk acts
upstream of Zyx, and likely requires Zyx to regulate growth. Over-
expression of D (UASD) leads to upregulation of DIAP1 (Fig. 4m) and
overgrowth of the wing pouch (Fig. 4n). Co-expression of UASD and
UASdCsk-IR phenocopies the effects of UASdCsk-IR over-expression
(Fig. 4o and p), suggesting that dCsk acts downstream of D. A
quantiﬁcation of the wing pouch size further conﬁrmed the epistatic
interactions between loss of dCsk and over-expression of Wts, Hpo,
Zyx or D (Fig. S2). Taken together, our epistasis interactions place
dCsk downstream of D and upstream of Wts in the Hippo signaling
pathway.
dCsk requires Yki to regulate growth
Since the signaling inputs in the Hippo pathway converge on the
Yki oncoprotein, we tested genetic epistasis interactions between
dCsk and Yki using similar genetic epistasis approaches. Compared to
wild-type (Fig. 5a and b), over-expression of Yki (nub-GAL4/UASYki)
leads to up-regulation of DIAP1 levels (Fig. 5c) and an overgrowth of
the wing pouch (Fig. 5d) in the nub domain. In comparison, loss of
dCsk (UASdCsk-IR; nub-GAL4/þ) leads to downregulation of DIAP1
(Fig. 1i) and an overgrowth of the wing pouch in imaginal discs
(Fig. 1g–i). Co-expression of dCsk-IR and Yki (UASdCsk-IR; nub-GAL4/
UASYki) resulted in up-regulation of DIAP1 levels (Fig. 5e) and an
Fig. 2. dCsk mutant cells are out competed by neighboring wild type cells. GFP labelled somatic clones of wild type (a–c) and loss of dCsk (d–f) is shown. Wild-type clones
(green in a) were induced in the eye imaginal discs using the MARCM approach, and stained with antibodies against activated Caspase 3 (Casp 3*) to assess the extent of cell
death (red in a). MARCM clones of dCsk (d–f) fail to cause large overgrowths, and Casp3* (red in d) is induced in dCsk mutant cells (green in d), which may account for their
elimination from the tissue due to cell competition.
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overgrowth of the wing pouch (Fig. 5f). The wild type adult wing
(Fig. 5k) is presented as reference. The size of the wing pouch and the
resulting adult wings appear very similar when comparing UASdCsk-
IR; nub-GAL4/UASYki (Fig. 5m) to either nub-GAL4/UASYki (Fig.5l) or
UASdCsk-IR; nub-GAL4/þ (Fig. 1g–i). However, the UASdCsk-IR; nub-
GAL4/UASYki double mutant wings show upregulation of DIAP1
expression similar to effects of over-expression of Yki. Taken together,
these data suggest that Yki may act downstream of dCsk.
To further clarify this epistatic relationship, we tested if the
overgrowth caused by loss of dCsk-IR is affected by heterozygosity
for ykiB5-the null allele for yki. It is well established that Hippo
signaling is sensitive to dose of Yki, and reduction in Yki levels is
known to affect loss of function phenotypes of other upstream genes
in the Hippo pathway (Baumgartner et al., 2010; Doggett
et al., 2011; Gilbert et al., 2011; Poernbacher et al., 2012; Sun and
Irvine, 2011; Verghese et al., 2012b; Wu et al., 2008). In wild type,
reduction in yki levels (ykiB5/þ) has no obvious effects on growth
(Fig. 5g and h). Heterozygosity of yki creates a sensitized background.
We observed that heterozygosity of ykiB5 resulted in reduction in the
overgrowth observed in the wing pouch of UASdCsk-IR; nub-GAL4/þ
wing discs (Fig. 5i and j compared to Fig. 1g and i), and DIAP1 levels
were restored (Fig. 5i). A quantiﬁcation of the wing pouch size also
Fig. 3. Yki activity is upregulated in dCsk mutant cells. (a–c) Wing imaginal discs from enGAL4 larvae stained for the anterior compartment marker Ci (green in a, gray in b)
and wild-type expression of ex697-lacZ (red in a, gray c) is shown. (d–f) Downregulation of dCsk using enGAL4 causes upregulation of ex697-lacZ (red in d, gray f). Ci expression
(green in d, gray in e) marks the anterior compartment where dCsk levels are wild-type. (g–i) Panels show enGAL4 domain marked using UASGFP (green in g, gray in h), and
wild-type expression pattern of fj-lacZ (red in g, gray in i). (j–l) Loss of dCsk in the enGAL4 domain (GFP positive- green in j, gray in k) leads to upregulation of fj-lacZ (red in j,
gray in l) in the posterior compartment.
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supported the genetic interaction data, where the overgrowths caused
by loss of dCsk or over-expression of Yki are similar to the effect of the
double mutant (Fig. 5n); and the overgrowth caused by loss of dCsk is
strongly suppressed by reduction in Yki levels (Fig. 5n). This suggests
that dCsk acts upstream of Yki, and may require Yki for regulating cell
proliferation/tissue growth.
dCsk acts downstream of Dachs
Our genetic epistasis places dCsk downstream of D. Therefore,
to further conﬁrm the dCsk-D epistasis, and to test if dCsk
regulates growth through the Hippo pathway, we tested if the
expression of fj-lacZ, the transcriptional target of Ft and Yki
Fig. 4. dCsk interacts with the Hippo pathway. Panels show wing imaginal discs fromwild-type (a and b), UASdCsk-IR; nub-GAL4/þ(c and d), nub-GAL4/þUASWts/þ(e and f),
nub-GAL4/UASHpo (i and j), nub-GAL4/þUASZyxRNAi/þ(m and n), and nub-GAL4UASDV5/þ(q and u) larvae stained for DIAP1 and Wg (respectively). Phenotypes of UASdCsk-IR;
nub-GAL4/þ; UASWts/þ(g and h), UASdCsk-IR; nub-GAL4/UASHpo (k and l), UASdCsk-IR; nub-GAL4/þ; UASzyxRNAi/þ(o and p) show reduction of the wing pouch size, whereas
UASdCsk-IR; nub-GAL4 UASDV5/þ(r and s) shows overgrowth. All co-expression phenotypes (g, k, o, and r) with dCsk-IR show down-regulation of DIAP1, which is
characteristic of UASdCsk-IR; nub-GAL4/þ .
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signaling, is affected in discs co-expressing UASdCsk-IR and UASD. fj
is expressed in a gradient in the wing pouch, with the highest
levels of fj expression coinciding with the presumptive (DV) wing
margin, and a gradient of decreasing fj expression that extends in
both the dorsal and ventral wing pouch (Fig. 6a) (Cho and Irvine,
2004; Ishikawa et al., 2008; Simon et al., 2010). Over-expression of
D causes moderate upregulation of fj-lacZ and mild hyperplasia
(Fig. 6b), whereas loss of dCsk leads to robust induction of fj-lacZ
expression and overgrowth (Fig. 3j–l; Fig. 6c). Co-expression of
UASdCsk-IR with UAS D caused robust overgrowth of the wing
pouch and robust induction of fj-lacZ expression (Fig. 6d) due to
increased Yki activity. These data also support a role of dCsk
downstream of D but upstream of Wts in the Hippo pathway.
Discussion
dCsk is as an upstream regulator of the hippo pathway
The Drosophila C-terminal src kinase (dCsk) is a tumor suppressor
gene, and loss of dCsk is reported to cause multiple defects in growth
regulation dependent on the tissue microenvironment, for example,
loss of dCsk in homozygous mutants causes extensive hyperplasia of
tissues due to increased proliferation and decreased apoptosis (Read
et al., 2004; Stewart et al., 2003; Vidal et al., 2006). Loss of dCsk in a
narrow band of cells or loss of dCsk in small patches in somatic
clones (Fig. 2) results in increased proliferation, decreased cell
adhesion, epithelial exclusion, upregulation of invasive/ cell migra-
tion related markers, and eventually apoptosis (Vidal et al., 2006).
Our characterization of the effects of loss of dCsk and genetic
interaction analysis showed that dCsk mutant cells induce the
transcriptional activity of the Hippo pathway effector Yki (Fig. 3).
Increased Yki activity leads to uncontrolled proliferation and forma-
tion of larger organs (Huang et al., 2005). Our genetic epistasis
places dCsk between Dachs and Warts, which corroborates with the
ﬁndings from earlier studies in ﬂies where dCsk was shown to act
upstream of Wts (Stewart et al., 2003). Further, the analysis of Yki
activity in cells deﬁcient for dCsk revealed that loss of dCsk induced
transcription of ex-lacZ and fj-lacZ, two well-established reporters
of Yki activity (Fig. 3). Thus, taken together these ﬁndings suggest
that dCsk is another upstream component of the Hippo pathway
that exerts its effects on tissue growth by affecting Yki activity
through Wts.
DIAP1 suppression and its implications on dCsk mediated growth
regulation
Interestingly, loss of dCsk shows a strong suppression of DIAP1
—as revealed by downregulation of DIAP1 protein (Fig. 1h), and
these effects on DIAP1 regulation likely occur through the Hippo
Fig. 5. dCsk requires Yki to regulate growth. (a and b) Wild-type wing imaginal discs stained for expression of DIAP1 (a) and Wg (b) are shown. (c and d) The effect of
overexpression of Yki (nub-GAL4/UASYki) on DIAP1 (c), and Wg (d) in wing imaginal discs is shown for comparison. Note the overgrowth of the wing pouch due to increased
Yki levels. (e and f) Co-expression of UASdCsk-IR (UASdCsk-IR; nub-GAL4/UASYki) leads to induction of DIAP1 (e) and overgrowth of wing pouch (f). (g and h) Wing imaginal
discs from FRT42D ykiB5/CyO larvae stained with antibodies against Diap1 (g) and Wg (h). (i and j) UASdCsk-IR; nub-GAL4/FRT42D ykiB5 wing discs showing reduced
expression of DIAP1 (i) and reduced growth of the wing pouch (j) due to heterozygosity of ykiB5. (k–m) Adult wings fromwild-type (k), nub-GAL4/UASYki (l) and UASdCsk-IR;
nub-GAL4/UASYki (m) ﬂies showing increased growth defects caused by co-expression of Yki and dCsk-IR. (n) The chart shows quantiﬁcation of wing pouch growth for wing
imaginal discs of the indicated genotypes. Asterisks indicate that the genotypes where there is signiﬁcant difference in wing pouch growth (n¼5, po0.05).
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signaling pathway as the Hippo response element in diap1—diap1
4.3GFP—is downregulated in dCsk mutant cells (Fig. S1). These
ﬁndings have many implications on the known effects of loss of
dCsk. First, loss of DIAP1 in small clones of dCsk may present them
for elimination (due to cell competition). Second, increased apop-
tosis observed in dCsk homozygous mutant discs may be due to
downregulation of DIAP1 (Langton et al., 2007). Third, the over-
growth of cells despite increased apoptosis and reduced DIAP1
levels in dCsk mutant discs may be explained by the faster rate of
proliferation which outcompetes the effects of cell elimination
from the developing tissue. Alternatively, the overgrowth in the
mutants may be caused by activation of Caspases that result in
apoptosis-induced proliferation, a well-documented phenomenon
in several growth contexts (Fan and Bergmann, 2008; Levayer and
Moreno, 2013). These effects of loss of dCsk are very similar to two
other tumor suppressor genes, scribble (scrib) and discs overgrown
(dco) that show similar effects on growth regulation. Homozygous
mutant animals cause dramatic overgrowths while generation of
small patches of mutant clones in somatic mosaics grows poorly
when compared to their wild-type twin clones, or neighboring
heterozygous cells (Chen et al., 2012; Enomoto and Igaki, 2011;
Guan et al., 2007; Verghese et al., 2012b). Furthermore, DIAP1 is
downregulated in all three mutants (Fig. 1) (Guan et al., 2007;
Verghese et al., 2012b), and genetic and molecular analyses place
these genes downstream of Fat in the Hippo pathway(Feng and
Irvine, 2009; Sopko et al., 2009; Verghese et al., 2012b).
dCsk requires Yki and acts upstream of Zyx to regulate growth
Although previous studies had identiﬁed some similarities in the
Csk loss of function phenotype to the loss of function phenotype of
tumor suppressor genes within the Hippo pathway (e.g., Sav or Wts),
a clear link between dCsk and the Hippo pathway was not estab-
lished (Pedraza et al., 2004; Read et al., 2004; Stewart et al., 2003;
Vidal et al., 2006). Our work links dCsk to the Hippo pathway, as our
ﬁndings suggest that dCsk requires Yki for growth regulation (Fig. 5).
This is because the overgrowth caused by loss of dCsk is strongly
suppressed by heterozygosity for yki. Loss of dCsk or overexpression
of Yki induces overgrowth; however, these genes interact synergis-
tically as the UASdCsk-IR, UASYki double mutant wings are larger
than those of the single mutants [dCsk-IR or Yki overexpressing]
animals. Thus, our data suggests that dCsk requires Yki to regulate
growth, and may also have other Yki-independent functions.
Our data place dCsk downstream of the atypical myosin Dachs,
and upstream of the Ajuba LIM protein Zyx and the Wts kinase
within the Hippo pathway (Fig. 4). D is known to bind Zyx, and D
also stimulates binding of Zyx to Wts (Mao et al., 2006; Rauskolb
et al., 2011). Zyx and D act downstream of Fat in the Hippo
pathway and regulate the stability of Wts (Rauskolb et al., 2011).
Thus, in the future it would be interesting to investigate if dCsk is a
part of the D/Zyx/Wts complex, or if it regulates Wts via phos-
phorylation dependent mechanisms, or if D or Zyx are involved in
the mechanisms that localize dCsk to the membrane, where dCsk
acts on its substrates.
SFK and the Hippo pathway
Csk is a known regulator of the activity of Src-family kinases
(SFKs) (Okada, 2012; Okada et al., 1991). Elevation of Src activity,
and increased Src expression is associated with increased prolifera-
tion, invasion and metastasis in several cancers (e.g., colon cancer)
(Cao et al., 2008; Cole et al., 2003). One mechanism that promotes
Fig. 6. dCsk acts downstream of Dachs in the Hippo pathway. A comparison of fj-lacZ expression is shown for wing imaginal discs from (a) wild-type, (b) nub-GAL4 UASDV5/þ ,
(c) UASdCsk-IR; nub-GAL4/þ , and (d) UASdCsk-IR; nub-GAL4 UASDV5/þ larvae.
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Src mediated tumor progression involves activation of focal adhe-
sion kinases (FAKs), JNK and matrix metalloproteases (MMPs),
which together cause decreased cell adhesion and degradation of
the basement membrane, two important criteria for tumor progres-
sion and metastasis (Je et al., 2014; Okada, 2012). Loss of dCsk in a
Drosophila model of tumor invasion revealed that the mutant cells
at the boundary (that contact the normal cells) show reduced cell
adhesion, which promotes their basal exclusion and migration.
Further studies showed that JNK, Rho1, E-Cadherin and p120Cn
(alpha Catenin) all promote increased cell migration and apoptosis
(Vidal et al., 2006, 2007). Furthermore, increased Src activity was
shown to induce JNK and the Hippo pathway, via Rac-Diaphanous,
and RAS-Mitogen activated protein kinase (MAPK) pathways, lead-
ing to propagation of Yki activity to non-cancer cells, which
contribute to the tumor phenotype (Enomoto and Igaki, 2013).
Taken together, our studies suggest that dCsk may reveal another
signal integration point between the SFK and the Hippo pathway,
two potent tumor suppressor networks.
In mammalian models, Csk is known to regulate SFK via
phosphorylation of a C-terminal regulatory tyrosine (equivalent to
Tyr-527). Besides, SFKs, substrates of Csk include Paxillin, c-Jun and
Lats (Okada, 2012; Pedraza et al., 2004; Stewart et al., 2003). These
proteins are part of different signaling pathways, supporting a role of
Csk in multiple signaling interactions during development. Another
important aspect of Csk function that remains unclear is its
localization with respect to that of its target substrates (e.g. SFK or
Lats or Paxilin), which are all preferentially expressed on the cell
membrane. Thus, Csk needs to be translocated to the membrane,
and several scaffolding/adapter proteins (e.g., Caveolin-1, Paxillin)
have been identiﬁed for their role in anchoring Csk to the membrane
(Martin, 2006; Okada, 2012). Interestingly recent studies have
emphasized the importance of localization of several key compo-
nents of the Hippo pathway to the apical membrane for their
regulation and function (Ho et al., 2010; Schroeder and Halder,
2012). Overall, if Csk is localized to the membrane via conserved
mechanisms, and if Csk interacts with other signaling pathways
using phosphorylation-independent mechanisms remain to be
determined. In summary, our data uncovers dCsk as a new input
in the Hippo signaling pathway, and reveals the intersection of the
Hippo and Src signaling pathways. Both these pathways are of wide
interest because of the roles they play in the regulation of normal
development, and the effects of misregulation of these pathways in
diseases like cancer.
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